Mild Cognitive Impairment

Evidence based Dementia Practice

Volumn , Issue , 2008, Pages 341-354

  Kluger, Alan ^a   Golomb, James ^b   Ferris, Steven H ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349412715     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470752340.ch25     Document Type: Chapter

References (85)

1. Albert, S.M., Michaels, K., Padilla, M. et al. (1999) Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. American Journal of Geriatric Psychiatry 7, 213-220.
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edition. American Psychiatric Association, Washington, D.C.
3. Berent, S., Giordani, B., Foster, N. et al. (1999) Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. Journal of Psychiatric Research 33, 7-16.
4. Blacker, D. & Tanzi, R.E. (1998) The genetics of Alzheimer disease: current status and future prospects. Archives of Neurology 55, 294-296.
5. Blennow, K., Davidsson, P., Wallin, A. & Ekman, R. (1995a) Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer's disease? Dementia 6, 306-311.
6. Blennow, K., Wallin, A., Agren, H., Spenger, C., Siegfried, J. & Vanmechelen, E. (1995b) Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Molecular and Chemical Neuropathology 26, 231-245.
7. Blesa, R., Adroer, R., Santacruz, P., Ascaso, C., Tolosa, E. & Oliva, R. (1996) High apolipoprotein E e4 allele frequency in age-related memory decline. Annals of Neurology 39, 548-551.
8. Bowen, J., Teri, L., Kukull, W., McCormick, W., McCurry, S.M. & Larson, E.B. (1997) Progression to dementia in patients with isolated memory loss. Lancet 349, 763-765.
9. Braak, H. & Braak, E. (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiology of Aging 18, 351-357.
10. Convit, A., de Leon, M.J., Golomb, J. et al. (1993) Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation. Psychiatric Quarterly 64, 371-387.
11. Crook, T., Bartus, R.T., Ferris, S.H., Whitehouse, P., Cohen, G.D. & Gershon, S. (1986) Age-associated memory impairment: proposed diagnostic criteria and measures of clinical changeaReport of a NIMH Work Group. Developmental Neuropsychology 2, 261-276.
12. Dal Forno, G., Corrada, M., Resnick, S. & Kawas, C. (1995) Prediction of the risk of dementia in clinically normal subjects. Abstract in Neurology 45 (Suppl. 4), A171.
13. Daly, E., Zaitchik, D., Copeland, M. et al. (2000) Predicting conversion to Alzheimer disease using standardized clinical information. Archives of Neurology 57, 675-680.
14. Davidsson, P., Jahn, R., Bergquist, J., Ekman, R. & Blennow, K. (1996) Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: a new biochemical marker for synaptic pathology in Alzheimer disease? Molecular and Chemical Neuropathology 27, 195-210.
15. Dawe, B., Procter, A. & Philpot, M. (1992) Concepts of mild cognitive impairment in the elderly and their relationship to dementia: a review. International Journal of Geriatric Psychiatry 7, 473-479.
16. de Leon, M.J., Golomb, J., George, A.E. et al. (1993) The radiologic prediction of Alzheimer's disease: the atrophic hippocampal formation. American Journal of Neuroradiology 14, 897-906.
17. Devanand, D.P., Folz, M., Gorlyn, M., Moesller, J.R. & Stern, Y. (1997) Questionable dementia: clinical course and predictors of outcome. Journal of the American Geriatric Society 45, 321-328.
18. Ebly, E.M., Hogan, D.B. & Parhad, I.M. (1995) Cognitive impairment in the nondemented elderly. Archives of Neurology 52, 612-619.
19. Ferris, S.H. & Kluger, A. (1996) Commentary on ageassociated memory impairment, age-related cognitive decline and mild cognitive impairment. Aging, Neuropsychology, and Cognition 3, 148-153.
20. Feskens, E.J.M., Havekes, L.M., Kalmijn, S., de Knijff, P., Launer, L.J. & Kromhout, D. (1994) Apolipoprotein e4 allele and cognitive decline in elderly men. British Medical Journal 309, 1202-1206.
21. Flicker, C., Ferris, S.H. & Reisberg, B. (1991) Mild cognitive impairment in the elderly: predictors of dementia. Neurology 41, 1006-1009.
22. Fox, N.C., Warrington, E.K., Freeborough, P.A. et al. (1996) Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain 119, 2001-2007.
23. Franssen, E.H., Reisberg, B., Kluger, A., Sinaiko, E. & Boja, C. (1991) Cognition-independent neurologic symptoms in normal aging and probable Alzheimer's disease. Archives of Neurology 48, 148-154.
24. Franssen, E.H., Souren, L.E.M., Torossian, C.L. & Reisberg, B. (1999) Equilibrium and limb coordination in mild cognitive impairment and mild Alzheimer's disease. Journal of the American Geriatric Society 47, 463-499.
25. Frisoni, G.B., Fratiglioni, L., Fastborn, J. et al. (2000) Mild cognitive impairment in the population and physical health: data on 1435 individuals aged 75 to 95. Journal of Gerontology: Medical Sciences 55A, M322-M328.
26. Fuld, P.A., David, M.M., Blau, A.D., Crystal, H. & Aronson, M.K. (1990) Object-memory evaluation for prospective detection of dementia in normal functioning elderly: predictive and normative data. Journal of Clinical and Experimental Neuropsychology 12, 520-528.
27. Galasko, D. (1998) Cerebrospinal fluid levels of A beta 42 and tau: potential markers of Alzheimer's disease. Journal of Neural Transmission 53 (Suppl.), 209-221.
28. Galasko, D., Chang, L., Motter, R. et al. (1998) High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Archives of Neurology 55, 937-945.
29. Golomb, J., Kluger, A., de Leon, M.J. et al. (1994) Hippocampal formation size in normal human aging: a correlate of delayed secondary memory performance. Learning and Memory 1, 45-54.
30. Golomb, J., Kluger, A., de Leon, M.J. et al. (1996) Hippocampal formation size predicts declining memory performance in normal aging. Neurology 47, 810-813.
31. Golomb, J., de Leon, M.J., Kluger, A., George, A.E., Tarshish, C. & Ferris, S.H. (1993) Hippocampal atrophy in normal aging: an association with recent memory impairment. Archives of Neurology 50, 967-973.
32. Graham, J.E.; Rockwood, K., Beattie, B.L. et al. (1997) Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349, 1793-1796.
33. Grober, E., Dickson, D., Sliwinski, M.J. et al. (1999) Memory and mental status correlates of modified Braak staging. Neurobiology of Aging 20, 573-579.
34. Grober, E., Lipton, R.B., Hall, C. & Crystal, H. (2000) Memory impairment on free and cued selective reminding predicts dementia. Neurology 54, 827-832.
35. Hampel, H., Teipel, S.J., Padberg, F. et al. (1999) Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease. Brain Research 823, 104-112.
36. Hughes, C.P., Berg, L., Danziger, W.L., Coben, L.A. & Martin, R.L. (1982) A new clinical scale for the staging of dementia. British Journal of Psychiatry 140, 566-572.
37. Iqbal, K. & Grundke-Iqbal, I. (1997) Elevated levels of tau and ubiquitin in brain and cerebrospinal fluid in Alzheimer's disease. International Psychogeriatrics 9 (Suppl. 1), 289-296.
38. Ishiguro, K., Ohno, H., Arai, H. et al. (1999) Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease. Neuroscience Letters 270, 91-94.
39. Ishii, K., Sasaki, M., Yamaji, S., Sakamoto, S., Kitagaki, H. & Mori, E. (1998a) Relatively preserved hippocampal glucose metabolism in mild Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 9, 317-322.
40. Ishii, K., Sasaki, M., Yamaji, S., Sakamoto, S., Kitagaki, H. & Mori, E. (1998b) Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease. Journal of Nuclear Medicine 39, 293-298.
41. Jack, C.R.J., Petersen, R.C., Xu, Y.C. et al. (1999) Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52, 1397-1403.
42. Jack, C.R.J., Petersen, R.C., Xu, Y.C. et al. (1997) Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 49, 786-794.
43. Kanai, M., Matsubara, E., Iso, K. et al. (1998) Longitudinal study of cerebrospinal fluid levels of tau, Aß1-40 and Aß1-42 (43) in Alzheimer's disease: a study in Japan. Annals of Neurology 44, 17-26.
44. Killiany, R.J., Gomez-Isla, T., Moss, M. et al. (2000) Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Annals of Neurology 47, 430-439.
45. Kluger, A., Ferris, S.H., Golomb, J., Mittelman, M.S. & Reisberg, B. (1999) Neuropsychological prediction of decline to dementia in nondemented elderly. Journal of Geriatric Psychiatry and Neurology 12, 168-179.
46. Kluger, A., Gianutsos, J.G., Golomb, J. et al. (1997) Patterns of motor impairment in normal aging, mild cognitive decline, and early Alzheimer's disease. Journal of Gerontology: Psychological Sciences 52B, 28-39.
47. Krasuski, J.S., Alexander, G.E., Horwitz, B. et al. (1998) Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biological Psychiatry 43, 60-68.
48. Kurz, A., Riemenschneider, M., Buch, K. et al. (1998) Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease. Alzheimer's Disease and Associated Disorders 12, 372-377.
49. Lovell, M.A., Xie, C. & Markesbery, W.R. (1998) Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51, 1562-1566.
50. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. & Stadlan, E.M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health & Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944.
51. Masur, D.M., Sliwinski, M., Lipton, R.B., Blau, A.D. & Crystal, H.A. (1994) Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 44, 1427-1432.
52. Matsubara, E., Hirai, S., Amari, M. et al. (1990) Alpha 1- antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Annals of Neurology 28, 561-567.
53. Mielke, R., Kessler, J., Szelies, B., Herholz, K., Wienhard, K. & Heiss, W.D. (1998) Normal and pathological aging - findings of positron-emission-tomography. Journal of Neural Transmission (Budapest) 105, 821-837.
54. Minoshima, S., Giordani, B., Berent, S., Frey, K.A., Foster, N.L. & Kuhl, D.E. (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Annals of Neurology 42, 85-94.
55. Mitrushina, M., Satz, P. & Van Gorp, W. (1989) Some putative cognitive precursors in subjects hypothesized to be at-risk for dementia. Archives of Clinical Neuropsychology 4, 323-333.
56. Mohs, R.C. & Ferris, S.H. (1998) Measuring response to treatment in Alzheimer's disease: what constitutes meaningful change? International Journal of Geriatric Pharmacology 1, S7-S14.
57. de la Monte, S.M., Volicer, L., Hauser, S.L. & Wands, J.R. (1992) Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease. Annals of Neurology 32, 733-742.
58. Morris, J.C., McKeel, D.W., Storandt, M. et al. (1991) Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathological distinction from normal aging. Neurology 41, 469-478.
59. Motter, R., Vigo-Pelfrey, C., Kholodenko, D. et al. (1995) Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Annals of Neurology 38, 643-648.
60. Petersen, R.C., Smith, G.E., Ivnik, R.J. et al. (1995) Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. Journal of the American Medical Association 273, 1274-1278.
61. Petersen, R.C., Smith, G.E., Waring, S.C., Ivnik, R.J., Tangalos, E.G. & Kokmen, E. (1999) Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology 56, 303-308.
62. Pietrini, P., Azari, N.P., Grady, C.L. et al. (1993) Pattern of cerebral metabolic interactions in a subject with isolated amnesia at risk for Alzheimer's disease: a longitudinal evaluation. Dementia 4, 94-101.
63. Poirier, J., Davignon, J., Bouthillier, D., Kogan, S., Bertrand, P. & Gauthier, S. (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342, 697-699.
64. Price, J.L. & Morris, J.C. (1999) Tangles and plaques in nondemented aging and 'preclinical' Alzheimer's disease. Annals of Neurology 45, 358-368.
65. Reiman, E.M., Uecker, A., Caselli, R.J. et al. (1998) Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Annals of Neurology 44, 288-291.
66. Reisberg, B. & Kluger, A. (1998) Assessing the progression of dementia: Diagnostic considerations. In: Clinical Geriatric Psychopharmacology (ed. C. Salzman), pp. 432-462. Williams & Wilkins, Baltimore.
67. Reisberg, B., de Ferris, S.H., Leon, M.J. & Crook, T. (1982) The global deterioration scale for assessment of primary degenerative dementia. American Journal of Psychiatry 139, 1136-1139.
68. Reisberg, B., de Ferris, S.H., Leon, M.J. et al. (1988) Stagespecific behavioral, cognitive, and in vivo changes in community residing subjects with age-associated memory impairment (AAMI) and primary degenerative dementia of the Alzheimer type. Drug Development Research 15, 101-114.
69. Reisberg, B., Finkel, S., Overall, J.E. et al. (1998) The Activities of Daily Living International Scale (ADL-IS): history and progress. Abstract. In: European Archives of Psychiatry and Clinical Neuroscience 248 (Suppl. 1), S4-S5.
70. Ritchie, K., Ledesert, B. & Touchon, J. (2000) Subclinical cognitive impairment: epidemiology and clinical characteristics. Comprehensive Psychiatry 41 (Suppl. 1), 61-65.
71. Ritchie, K. Artero, S. & Touchon, J. (2001) Classification criteria for mild cognitive impairment: a populationbased validation study. Neurology 56, 37-42.
72. Ritchie, K. & Touchon, J. (2000) Mild cognitive impairment: conceptual basis and current nosological status. Lancet 355, 225-228.
73. Robinson-Whelen, S. & Storandt, M. (1992) Immediate and delayed prose recall among normal and demented adults. Archives of Neurology 49, 32-34.
74. Rubin, E.H., Morris, J.C., Grant, E.A. & Vendegna, T. (1989) Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Archives of Neurology 46, 379-382.
75. Saunders, A.M., Strittmatter, W.J., Schmechel, D. et al. (1999) Association of apolipoprotein E allele e4 with lateonset familial and sporadic Alzheimer's disese. Neurology 43, 1467-1472.
76. Schwagerl, A.L., Mohan, P.S., Cataldo, A.M., Vonsattel, J.P., Kowall, N.W. & Nixon, R.A. (1995) Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. Journal of Neurochemistry 64, 443-446.
77. Storandt, M. & Hill, R.D. (1989) Very mild senile dementia of the Alzheimer type. II. Psychometric test performance. Archives of Neurology 46, 383-386.
78. Storandt, M., Botwinick, J., Danziger, W.L., Berg, L. & Hughes, C.P. (1984) Psychometric differentiation of mild senile dementia of the Alzheimer type. Archives of Neurology 41, 497-499.
79. Taylor, E.M. (1959) Psychological Appraisal of Children with Cerebral Deficits. Harvard University Press. Cambridge, MA.
80. Tierney, M.C., Szalai, J.P., Snow, W.G. et al. (1996a) A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology 46, 149-154.
81. Tierney, M.C., Szalai, J.P., Snow, W.G. et al. (1996b) Prediction of probable Alzheimer's disease in memoryimpaired patients: a prospective longitudinal study. Neurology 46, 661-665.
82. Wechsler, D. (1987) Wechsler Memory ScaleaRevised. Psychological Corporation/Harcourt Brace Javanovich, San Antonio. Wolf, H., Grunwald, M., Ecke, G.M. et al. (1998) The prognosis of mild cognitive impairment in the elderly. Journal of Neural Transmission 54, 31-50.
83. Yesavage, J.A., Kraemer, H., Noda, A. et al. (2000) MCI: epidemiology and risk factors. Presentation at: European Conference on Brain Research, Villars sur Ollon Switzerland, April.
84. Zaudig, M. (1992) A new systematic method of measurement and diagnosis of 'mild cognitive impairment' and dementia according to ICD-10 and DSM-III-R criteria. International Psychogeriatrics 4, 203-219.
85. Zaudig, M., Mittelhammer, J., Hiller, W. et al. (1991) SIDAMaa structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R. Psychological Medicine 21, 225-236.